CHENNAI, India -- Nasdaq-listed health technology firm Veradigm on Wednesday announced a strategic investment in Singapore- and New York-headquartered data analytics startup Holmusk.
Veradigm (formerly Allscripts Healthcare Solutions) led Holmusk's $45 million Series B financing round, which was joined by current investors including Singapore-based Heritas Capital, Health Catalyst Capital, Novartis (dRx Capital) and Northwell Holdings, the venture investment arm of Northwell Health.
